[EN] TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS<br/>[FR] HÉTÉROCYCLES TRICYCLIQUES EN TANT QU'INHIBITEURS DE PROTÉINE BET
申请人:INCYTE CORP
公开号:WO2014143768A1
公开(公告)日:2014-09-18
The present invention relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.
TRICYCLIC HETEROCYCLES FOR USE AS BET PROTEIN INHIBITORS
申请人:Incyte Holdings Corporation
公开号:EP3194406A1
公开(公告)日:2017-07-26
[EN] TRICYCLIC HETEROCYCLES FOR USE AS BET PROTEIN INHIBITORS<br/>[FR] HÉTÉROCYCLES TRICYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DES PROTÉINES BET
申请人:INCYTE CORP
公开号:WO2016044130A1
公开(公告)日:2016-03-24
The present disclosure relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.